Column Capital Advisors’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
$1.6M Buy
10,263
+1,997
+24% +$330K 0.24% 44
2023
Q2
$1.37M Sell
8,266
-52
-0.6% -$8.39K 0.19% 48
2023
Q1
$1.29M Sell
8,318
-1,639
-16% -$265K 0.19% 48
2022
Q4
$1.76M Buy
9,957
+74
+0.7% +$12.8K 0.29% 36
2022
Q3
$1.61M Buy
9,883
+13
+0.1% +$2.2K 0.33% 39
2022
Q2
$1.75M Buy
9,870
+7
+0.1% +$1.25K 0.34% 37
2022
Q1
$1.75M Sell
9,863
-722
-7% -$123K 0.32% 36
2021
Q4
$1.81M Buy
10,585
+556
+6% +$91K 0.35% 39
2021
Q3
$1.62M Buy
10,029
+6
+0.1% +$1.02K 0.34% 36
2021
Q2
$1.65M Buy
10,023
+467
+5% +$77.3K 0.35% 35
2021
Q1
$1.57M Sell
9,556
-71
-0.7% -$11.5K 0.35% 34
2020
Q4
$1.51M Sell
9,627
-432
-4% -$63.8K 0.38% 28
2020
Q3
$1.5M Sell
10,059
-188
-2% -$27.8K 0.46% 26
2020
Q2
$1.44M Sell
10,247
-197
-2% -$28.7K 0.48% 24
2020
Q1
$1.37M Sell
10,444
-215
-2% -$30.5K 0.56% 22
2019
Q4
$1.55M Buy
+10,659
New +$1.45M 0.79% 16

Other funds holding JNJ

Column Capital Advisors's JNJ Position: Q3 2023 in Review

Column Capital Advisors increased its Johnson & Johnson (JNJ) stake by 24% in Q3 2023, buying an estimated $330K and bringing the position to 10,263 shares worth $1.6M. The position accounts for 0.24% of the portfolio, ranked #44.

Column Capital Advisors first reported a position in JNJ in Q4 2019 and has held it in 16 quarters since. The position peaked at $1.81M in Q4 2021. 3,681 funds tracked by Wall St. Rank hold JNJ as of Q3 2023.

  • Column Capital Advisors held 10,263 shares of Johnson & Johnson worth $1.6M as of Q3 2023.
  • Column Capital Advisors bought 1,997 Johnson & Johnson shares in Q3 2023, an estimated $330K.
  • Johnson & Johnson made up 0.24% of Column Capital Advisors's portfolio in Q3 2023, its #44 holding.
  • Column Capital Advisors first reported a position in Johnson & Johnson in Q4 2019 and has held it in 16 quarters since.
  • Column Capital Advisors's Johnson & Johnson position peaked at $1.81M in Q4 2021.
  • 3,681 funds tracked by Wall St. Rank held Johnson & Johnson as of Q3 2023.

Based on Column Capital Advisors's 13F filing for Q3 2023, filed 3 Nov 2023.